The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic Fibrosis
Clinical trial NCT03870841 · TERMINATED
Trial details
- NCT number
- NCT03870841
- Sponsor
- Pulmocide Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-03
- Primary completion
- 2020-06-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.